 Melisa Tanverdi
Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 8 | 2026 | 1768 | 1.520 |
Why?
| | Anti-Asthmatic Agents | 4 | 2026 | 252 | 1.100 |
Why?
| | Dexamethasone | 4 | 2026 | 372 | 0.960 |
Why?
| | Emergency Service, Hospital | 6 | 2026 | 2313 | 0.950 |
Why?
| | Transplant Recipients | 3 | 2025 | 180 | 0.850 |
Why?
| | Bacterial Infections | 1 | 2025 | 246 | 0.760 |
Why?
| | Anaphylaxis | 1 | 2022 | 102 | 0.670 |
Why?
| | Drug Monitoring | 1 | 2024 | 395 | 0.630 |
Why?
| | Adrenal Cortex Hormones | 5 | 2026 | 479 | 0.630 |
Why?
| | Pneumonia | 1 | 2025 | 631 | 0.580 |
Why?
| | Heart Transplantation | 1 | 2025 | 736 | 0.560 |
Why?
| | Patient Discharge | 1 | 2024 | 983 | 0.510 |
Why?
| | Child | 13 | 2026 | 22657 | 0.350 |
Why?
| | Bacteremia | 2 | 2023 | 221 | 0.320 |
Why?
| | Child, Preschool | 8 | 2026 | 11799 | 0.320 |
Why?
| | Acute Disease | 2 | 2024 | 1031 | 0.310 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2025 | 25 | 0.230 |
Why?
| | Tooth Abnormalities | 1 | 2025 | 16 | 0.230 |
Why?
| | Oscillometry | 1 | 2025 | 35 | 0.230 |
Why?
| | Albuterol | 1 | 2025 | 73 | 0.220 |
Why?
| | Adolescent | 7 | 2026 | 22453 | 0.220 |
Why?
| | Bronchodilator Agents | 1 | 2025 | 183 | 0.220 |
Why?
| | Intellectual Disability | 1 | 2025 | 175 | 0.200 |
Why?
| | Respiratory Sounds | 1 | 2024 | 105 | 0.200 |
Why?
| | Retrospective Studies | 7 | 2026 | 17101 | 0.190 |
Why?
| | Cataract | 1 | 2025 | 238 | 0.190 |
Why?
| | Treatment Failure | 1 | 2024 | 365 | 0.190 |
Why?
| | Meningitis, Bacterial | 1 | 2023 | 45 | 0.190 |
Why?
| | Wearable Electronic Devices | 1 | 2023 | 63 | 0.180 |
Why?
| | Magnesium | 1 | 2022 | 155 | 0.180 |
Why?
| | Epinephrine | 1 | 2022 | 155 | 0.180 |
Why?
| | Administration, Intravenous | 1 | 2022 | 170 | 0.170 |
Why?
| | Shock, Septic | 1 | 2023 | 216 | 0.170 |
Why?
| | Recurrence | 1 | 2024 | 1135 | 0.160 |
Why?
| | Urinary Tract Infections | 1 | 2022 | 203 | 0.160 |
Why?
| | Vitamin K Deficiency | 1 | 2019 | 9 | 0.150 |
Why?
| | Contusions | 1 | 2019 | 25 | 0.150 |
Why?
| | Medicaid | 1 | 2024 | 462 | 0.150 |
Why?
| | Scrotum | 1 | 2019 | 24 | 0.150 |
Why?
| | Humans | 14 | 2026 | 144957 | 0.150 |
Why?
| | Male | 9 | 2026 | 72406 | 0.140 |
Why?
| | Thymus Gland | 1 | 2019 | 311 | 0.140 |
Why?
| | Female | 8 | 2026 | 78376 | 0.130 |
Why?
| | Phenotype | 1 | 2025 | 3164 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1915 | 0.130 |
Why?
| | Infant | 3 | 2025 | 10039 | 0.120 |
Why?
| | Kidney Transplantation | 1 | 2022 | 704 | 0.120 |
Why?
| | Liver Transplantation | 1 | 2023 | 823 | 0.120 |
Why?
| | Prospective Studies | 2 | 2025 | 7997 | 0.110 |
Why?
| | Quality of Life | 1 | 2024 | 3192 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2024 | 11695 | 0.080 |
Why?
| | United States | 2 | 2025 | 15988 | 0.080 |
Why?
| | Airway Resistance | 1 | 2025 | 38 | 0.060 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 76 | 0.060 |
Why?
| | Heterozygote | 1 | 2025 | 315 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 547 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 615 | 0.050 |
Why?
| | Respiratory Rate | 1 | 2023 | 23 | 0.050 |
Why?
| | Bronchiolitis | 1 | 2024 | 87 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2023 | 289 | 0.040 |
Why?
| | Prednisolone | 1 | 2020 | 66 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2025 | 749 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2024 | 6434 | 0.040 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2019 | 4 | 0.040 |
Why?
| | Mediastinum | 1 | 2019 | 23 | 0.040 |
Why?
| | Genital Diseases, Male | 1 | 2019 | 17 | 0.040 |
Why?
| | Prednisone | 1 | 2020 | 221 | 0.040 |
Why?
| | Vitamin K | 1 | 2019 | 45 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2025 | 1167 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 10792 | 0.040 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 62 | 0.040 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 106 | 0.030 |
Why?
| | Administration, Oral | 1 | 2020 | 848 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2925 | 0.030 |
Why?
| | Registries | 1 | 2026 | 2385 | 0.030 |
Why?
| | Health Promotion | 1 | 2023 | 774 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1495 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5872 | 0.020 |
Why?
| | Primary Health Care | 1 | 2020 | 1734 | 0.020 |
Why?
| | Adult | 1 | 2025 | 40506 | 0.010 |
Why?
|
|
Tanverdi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|